SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-003031
Filing Date
2017-11-14
Accepted
2017-11-14 16:36:10
Documents
49
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_10q-093017.htm 10-Q 300836
2 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 8843
3 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 8807
4 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 4145
  Complete submission text file 0001683168-17-003031.txt   1810808

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20170930.xml EX-101.INS 220393
6 XBRL SCHEMA FILE xbio-20170930.xsd EX-101.SCH 25971
7 XBRL CALCULATION FILE xbio-20170930_cal.xml EX-101.CAL 41017
8 XBRL DEFINITION FILE xbio-20170930_def.xml EX-101.DEF 86023
9 XBRL LABEL FILE xbio-20170930_lab.xml EX-101.LAB 177311
10 XBRL PRESENTATION FILE xbio-20170930_pre.xml EX-101.PRE 143646
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 171202167
SIC: 2834 Pharmaceutical Preparations